s/s ---* All mouse strains tested were viremic (-10 ~ XC-PFU/ml, ~104 SFFU/ml) early after FV infection, but those having the Rfv-3 r/~ genotype developed serum anti-FV antibody and began to clear the viremia about 25 d after infection (19) (20) (21) 25 , and our unpublished data). * All mice in this table developed leukemic splenomegaly (spleen wt 1-4 g) 10-15 d after FV inoculation. Certain strains (see table) recovered spontaneously between 25 and 40 d postinoculation, and spleen weights remained normal thereafter (16, 17) .
Using a viral dose of 1,000 SFFU, (B10.A X A.BY)F1 mice did not recover from FV-induced splenomegaly. However, if given 100 or 10 SFFU, a significant number recovered (16, 17) .
and IgG PFC responses were previously determined to occur at 4 and 7 d postimmunization, respectively. Therefore, the antigen-specific IgM and IgG PFC responses were determined by inoculating mice with SRBC 4 or 7 d before assay. To determine the PFC responses to a secondary immunization, mice were inoculated with SRBC and FV simultaneously, boosted with SRBC 23 d later, and assayed for antigen-specific IgM and IgG PFC 7 d after the booster immunization. Antigen-specific IgM PFC were defined as those plaques that developed without the addition of rabbit anti-mouse IgG (RAMIgG). The number of antigen-specific IgG-secreting PFC was determined by subtracting the direct PFC response from the facilitated response. The number of splenic anti-TNP IgMsecreting cells was determined by using the slide monolayer technique, except TNPconjugated SRBC were used (24) . Background anti-SRBC and anti-TNP PFC responses in unimmunized normal and FV-infected mice were consistently below 200 PFC/spleen. Plasma was collected at intervals after FV infection and SRBC immunization, and used to determine circulating virus and anti-SRBC antibody titers. Titers of F-MuLV were determined by plating plasma dilutions onto SC-1 cells and counting infected cell foci visualized by indirect immunofluorescence using F-MuLV-specific MAb 48, as described previously (22) .
Plasma samples were divided and tested for anti-SRBC antibodies either directly, or with the addition of RAMIgG, or after treatment with 2-ME. Briefly, 50 #1 of serially diluted plasma, prepared in PBBS containing 2% FCS, was added to the pelleted cells from 25 #1 of a 1% SRBC suspension. Anti-SRBC antibody titers were expressed as the reciprocal of the highest serum dilution that showed a distinct agglutination pattern. Direct titers were determined by incubating plasma samples with SRBC for 4 h at 4°C. Indirect titers were determined by incubating plasma samples with SRBC for 45 min at room temperature, washing three times with PBBS containing 2% FCS, adding 50 #1 of a 1:100 dilution of RAMIgG and incubating for 4 h at 4°C. Some plasma samples were treated with 0.1 M 2-ME at 37°C for 30 min to inactivate IgM antibodies, diluted, added to SRBC, and incubated at 4°C for 4 h.
Statistical
Methods. The Student's t test for unpaired data was used to determine the level of significance between the means of samples.
Results
Immunosuppression in Rfv-3 r/s and Rfv-3 ~/~ Mice. (B10.A × A.WySn)F1, Rfv-3 'IS, mice were compared with BALB/c Rfv-3 ~/s mice for their ability to respond immunologically to SRBC. BALB/c mice were used as controls because of their known susceptibility to FV-induced immunosuppression (5), and their lack of a humoral immune response to FV during active infection (20 and Table I ). The direct PFC response was assayed at 25 d after FV infection, and mice having the Rfv-3 r/s genotype were found to be as suppressed as mice having the Rfv-3 ~/s genotype (Table II) . In both strains, the direct PFC response was decreased by Table I ).
Comparison of lmmunosuppression in H-2-congenic Mice
Having the Rfv-3 r/s Genotype. Genes within the H-2 complex have a strong influence on FV-induced leukemia. By examining congenic Rfv-3 r/s mice that differed only at the H-2 locus, we were able to study the effect of H-2 genotype on the development of FV-induced immunosuppression. We assayed the anti-SRBC immune response of FV-infected mice at 40 d after FV inoculation, when these mice were responding immunologically to FV (Table I ). At this time, H-2 a/a mice had gross splenomegaly and showed depressed 7-d IgG anti-SRBC PFC responses and lowered IgM anti-SRBC PFC levels at both times tested (4 and 7 d post-SRBC immunization) (Fig. I) . At this same time, H-2 "/b mice also had severe splenomegaly, but showed no depression in anti-SRBC PFC of the IgG class, and depression of the IgM PFC response only at 4 d postimmunization, returning to normal by day 7 (Fig. 1) . These results indicated that FV-induced immunosuppression was strongly influenced by genes within the H-2 complex. As expected, the homozygous H-2 b/b genotype was associated with both recovery from leukemia and lack of immunosuppression (data not shown). However, heterozygous H-2 ~/b mice, which did not recover from leukemia, nevertheless failed to develop FV-induced suppression of the IgG anti-SRBC response, and had only transient suppression of the IgM response.
Kinetics ofFV-induced Immunosuppression.
To assess the role of viremia in FVinduced immunosuppression, we studied the immune response of H-2 a/a Rfv-3 r/s mice at various times after FV infection. Early (13 d) after FV-infection, when all mice were viremic, the SRBC-specific IgG PFC response was found to be depressed (Fig. 2 ). This response was also found to be suppressed (>l,000-fold) at 25 and 40 d post-FV inoculation, when most mice had eliminated the viremia. In contrast, the 4-and 7-d antigen-specific IgM PFC responses were not significantly suppressed early after FV infection, but were suppressed later during the disease. 
Comparison of H-2-congenic Mice
Having the Rfv-3 ~/~ Genotype. We studied H-2-congenic mice having the A strain background genes to assess the influence of H-2 genotype on FV-induced immunosuppression in Rfv-3 s/s mice. These mice do not produce virus-neutralizing antibody, and remain viremic until death ( Table I ). A.BY (H-2 b/b) and A/WySn (H-2 "/a) mice were assayed for anti-SRBC PFC at 40 d after FV infection, at which time both strains of mice had similar levels of viremia (>105 FFU/ml). The IgM PFC responses in FV-infected A/WySn mice were slightly suppressed (less than one order of magnitude) at 4 and 7 d after SRBC immunization (Fig. 3) . A.BY mice had a suppressed IgM PFC response at 4 d after SRBC-immunization (<1.5 log10), but not at day 7. The IgG PFC response was suppressed in all H-2 a/a mice tested (p < 0.001), and the majority of these mice (five out of nine) were >99% suppressed. In contrast, in mice having the H-2 b/b genotype, immunosuppression of the IgG response was marginal (i.e., not significant at p < 0.001, but significant at p < 0.05), and only one animal was >99% suppressed. Thus, lack of severe suppression of the IgG PFC response correlated with the presence of the H-2 bm genotype, even in the presence of the Rfv-3 s/~ genotype and other A strain genes.
Analysis of Plasma Anti-SRBC Antibody. Plasma anti-SRBC antibody was measured to determine whether the suppressed PFC responses were spleen-specific phenomena or whether the suppression was systemic. Plasma anti-SRBC antibody titers were reduced in FV-infected H-2 a/a mice at 4 and 7 d after SRBC immunization (Table III) . The suppressed antibody responses correlated with the reduced PFC responses of these mice. Also, the lack of production of IgG anti-SRBC was evident, since most antibodies from FV-infected mice immunized 7 d previously.with SRBC were susceptible to inactivation by treatment with 2-ME, and thus were of the IgM class. In contrast, antibodies obtained on day 7 from control uninfected mice were not susceptible to this treatment. Plasma anti-SRBC antibody titers were performed in conjunction with all PFC assays. In all instances, alterations in the PFC responses were reflected in the plasma antibody titers. Thus, the suppressed immunological responsiveness to SRBC appeared to be not only a local suppression of the PFC response in the spleen, but a systemic suppression of the humoral antibody response. the effect of FV infection on the secondary immune response, we chose to examine H-2 a/", Rfv-3 "/S mice, since these mice responded immunologically to FV, but were suppressed to a primary SRBC immunization. These mice developed a normal anti-SRBC IgM PFC response at 7 d after the secondary immunization, but had a depressed IgG response (Fig. 4) . The majority of FV-infected mice had no detectable levels of SRBC-specific IgG PFC, and those that did respond had significantly lower levels than uninfected mice. Also, some mice were immunized with SRBC 7 d before infection with FV, boosted 23 d after 
Suppression of Secondary Immune Response in H-

FV-infection, and assayed for PFC 7 d after the booster immunization (data not shown). These mice developed normal IgM PFC responses, but had suppressed
Plasma Anti-SRBC Titers of FV-Infected and Uninfected H-2 =/° Rfv-3 "/~ Mice
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Anti-SRBC titer (logs)* Rabbit anti-mouse Not treated 2-ME Ig secondary IgG PFC responses. Three of four FV-infected mice had IgG PFC responses suppressed by 90-99%. Therefore, the secondary IgG response appeared to be sensitive to the effects of FV infection, even if the primary SRBC immunization was given before FV infection.
Suppression of PFC Response to a T Cell-independent Antigen in H-2 ~/~, Rfv-3 ,/s Mice.
To determine whether B lymphocyte function was altered during FV infection, we examined the PFC response of spleen cells from FV-infected mice to the T cell-independent antigen, TNP-Ficoll. (B10.A X A/WySn)F1, H-2 'l/~, Rfv-3 r/s mice failed to produce normal levels of direct TNP PFC when assayed at 25 d after FV infection (Table IV) . This response was suppressed by >99%, which indicated that B lymphocyte function was markedly reduced in these FV-infected mice. 
Discussion
Our results show that genes within the H-2 complex influenced FV-induced immunosuppression. The IgG PFC response in mice having the H-2 ~/b or H-2 bm genotype was not significantly suppressed, whereas in mice having the H-2 a/a genotype, this response was suppressed both early (13 d) and late (25 and 40 d) during FV disease. In the case of (B 10.A X A/WySn)Fj, H-2 ~/~ mice, this finding was surprising, since these mice have the Rfv-3 r/s genotype and thus they respond immunologically to FV (19, 21) . Our data indicated that the Rfv-3 gene alone did not appear to convey resistance to FV-induced immunosuppression.
Only a few studies have been concerned with defining the genetic regulation of FV-induced immunosuppression. Kumar et al. (12, 13) described a gene,  that maps outside the H-2 complex and regulates susceptibility to FV-induced suppression of lymphocyte mitogenesis in vitro and to PFC responses in vivo. In our previous (18, 19, 21) and present experiments, we did not observe the effect of the Fv-3 gene. This may have been due to technical differences such as FV dose used, or to genetic differences in the mice tested.
Massive splenomegaly often accompanies FV disease, and a depressed splenic PFC response could be due to alterations in specific splenic functions rather than general systemic immunosuppression. However, several lines of evidence argue against this interpretation. PFC responses were calculated as PFC/spleen and not PFC/10 ~ nucleated cells; therefore, the large number of nucleated leukemic ceils would not affect the calculation. Also, plasma anti-SRBC responses were depressed whenever we observed suppressed PFC responses. Thus, we were observing a systemic suppression and not an organ-specific phenomenon. Lastly, mice having the H-2 "/b or H-2 ~/~ genotype had similarly enlarged spleens at both 13 and 40 d after FV infection, but only H-2 "/a mice had a suppressed IgG PFC response. Therefore, FV-induced splenomegaly itself was not sufficient to cause this immunosuppression. However, it is possible that FV-induced changes in splenic architecture could alter interactions among cells of the immune system. This might explain the transient suppression of the IgM PFC responses in splenomegalic H-2 "/b mice.
Similarities are evident between the immunosuppression we observed in (B 10.A × A/WySn)F~ mice and that found previously in other susceptible strains of mice inoculated with FV. Primary IgM PFC responses and secondary lgG PFC responses were suppressed in FV-infected BALB/c mice (5, 26, 27) . In some instances, serum antibody titers were also shown to be suppressed (5, 26) . Our data indicated that the IgM PFC response was not as sensitive as the IgG PFC response to suppression, since the IgM PFC response was only transiently suppressed and returned to normal levels by 7-10 d after immunization (Figs. 1  and 2) , whereas both the primary and secondary IgG PFC responses were exquisitely sensitive to FV-induced immunosuppression (Figs. 1 and 4) .
The suppression we observed in both Ig classes could be due to altered B or T cell functions, since both IgM and IgG responses to SRBC are T celldependent. However, since IgG responses require additional T cell help to make the class switch from IgM to IgG, the increased suppression of IgG PFC might be explained by lack of this T cell function. By examining the immune response of FV-infected mice to a T cell-independent antigen, B cell function could be tested directly. (B10.A X A/WySn)F~, H-2 a/a mice failed to generate normal numbers of PFC cells to TNP-FicoI1, which indicated that B lymphocyte function was also altered (Table IV) . Therefore, FV-induced immunosuppression appeared to be a complex phenomenon probably involving many different cell types of the immune system. This conclusion is consistent with previous observations (28, 29) that FV can infect and/or transform several different hemopoietic cell types, including B and T lymphocytes, myeloid cells, erythroid cells, and megakaryocytes.
The mechanism(s) of retrovirus-induced immunosuppression is not well understood. Both UV-inactivated retroviruses and retroviral components can be immunosuppressive, suggesting that viral proteins may be responsible for the induction of the suppressed condition. In the feline leukemia virus system, UVinactivated virus and pl 5E protein have been shown to cause suppression of the blastogenic response to T cell mitogens, inhibition of inflammatory macrophage accumulation, and abrogation of tumor immunity (3, 4, (30) (31) (32) (33) . However, our experiments indicated that high titers of F-MuLV helper virus were not solely responsible for the induction or maintenance of the suppressed condition. For instance, (B10.A × A/WySn)F1 mice were viremic and suppressed early (13 d) during FV disease, and remained suppressed even after clearing the virus (40 d) ( Figs. 1 and 2) . Also, only a small percentage of spleen cells from these mice expressed viral proteins or released infectious virus (21, 34, 35) . Thus, there must be a mechanism by which the immunosuppressed state was maintained even when levels of infectious virus and viral proteins were reduced by 1,000-fold. Conversely, A.BY mice had very high titers of circulating virus (>10 ~ FFU/ml), yet they were not severely immunosuppressed (Fig. 3) . Thus, in contrast to the feline system, it appears unlikely that circulating F-MuLV helper virus or FMuLV proteins were the sole cause of the induction or maintenance of the immunosuppression.
The importance of the SFFV component of the FV complex in inducing the immunosuppressed condition is not known. SFFV has the genetic structure of a defective recombinant virus (36) , similar to dual-tropic recombinant mink cell focus (MCF)-inducing virus described previously (37, 38) . A recent study by Mosier et al. (39) indicated that a MuLV mixture containing MCF viruses was required for induction of an immunosuppressive lymphoproliferative disease. Therefore, it is possible that SFFV might have a similar effect in the FV system. Furthermore, our FV preparations contained nondefective MCF MuLV, which might have been involved in the immunosuppression observed.
FV-infected (B10.A × A/WySn)F1, H-2 a/~ mice have interesting analogies to patients with acquired immunodeficiency syndrome (AIDS). (a) In both, a retrovirus infection leads to profound immunosuppression of adult immunocompetent hosts. (b) Virus-specific antibodies are found in both cases (19, 21, (40) (41) (42) , yet both are immunologically compromised with regard to new immunological challenges (2) . (c) Only low levels of infectious virus are found. In the FV system, this is due to the presence of antiviral antibodies (35) , and in AIDS, the antiviral humoral response (40-42) might be partially responsible for the low number of infected cells observed. (d) HTLV-III/LAV causes a marked decrease in the number of T helper cells, which results in an abnormal helper/suppressor cell ratio (43, 44) . Although we have no data concerning this ratio in (B10.A × A/WySn)F1 mice, our data suggested altered T helper cell function. The similarities of the two diseases and the common retroviral etiology warrant further studies concerning the virus-specific and antigen-specific immune responses of this murine model.
Recently, the Laterjet-Duplan strain of radiation leukemia virus was shown (39) to cause profound immunosuppression in mice having the H-2 b/b genotype. Conversely, in the FV system, the H-2 b/b genotype influences recovery from disease and resistance to immunosuppression (17) . Thus, in retrovirus infections, the same H-2 haplotype can have markedly different effects on recovery and/or immunosuppression, depending on the strain of retrovirus involved. By analogy, if there exist multiple retroviruses that cause AIDS (45, 46) , it is possible that a single HLA type might have different effects on the susceptibility to different virus strains.
Summary
Friend murine leukemia virus complex (FV)-induced immunosuppression was studied by assaying splenic anti-SRBC PFC responses and plasma antibody titers in mice at various times after FV inoculation. Genes located within the H-2 complex were found to influence resistance to FV-induced immunosuppression. Near normal responses were observed in mice having the H-2 a/b or H-2 b/b genotype, whereas mice having the H-2 a/~ genotype were suppressed. This H-2 effect was observed not only in mice having heterozygous C57BL/10 × A background genes, including Rfv-3 r/~, but also was apparent in mice having homozygous A-strain background genes, including Rfv-3 ~/~. Therefore, the Rfv-3 gene did not appear to convey resistance to FV-induced immunosuppression. The suppression in susceptible H-2 a/a mice was characterized by a partial suppression of the IgM response and a profound suppression of both the primary and secondary IgG responses. Neither splenomegaly nor viremia alone appeared to be sufficient for the induction or maintenance of the immunosuppression. The mechanism of suppression was unclear, but both B lymphocyte and T lymphocyte functions appeared to be altered.
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